Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Perrigo's Combo For Growth: Bolt-on Acquisitions And New Products

Nov 07 2019

• By Malcolm Spicer

Computer key - 3rd quarter - Image

Related Content

FDA Finds Ranitidine Poses Little Risk, But Concerns Linger

Nov 04 2019

Perrigo Faces $370m Tax Payment From Second IRS Audit Linked To Elan Deal

Nov 07 2019

Ranir Oral Care Deal Could Brighten Perrigo's Turnaround Chances

May 13 2019

Infant Formula Woes Turn Perrigo's Q2 Sour Despite Solid Americas’ OTC Sales

Aug 09 2019

Perrigo Feeds OTC Brand Play With Prevacid As GSK Thins Consumer Lineup

Sep 05 2019

Perrigo Pivots To 'Self Care' For 'Massive Opportunity' Beyond OTC Drugs

Nov 10 2018

Related Companies

Perrigo Company PLC

GSK plc

Additional Topics

International United States OTC Drugs Sales & Earnings Business Strategies Launches Advertising, Marketing & Sales Commercial Companies M & A Manufacturing Deals Consumer

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window